Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
B M Beadle, R A Nicholas, B K Shoichet
Index: Protein Sci. 10(6) , 1254-9, (2001)
Full Text: HTML
Abstract
Penicillin-binding proteins (PBPs) catalyze the final stages of bacterial cell wall biosynthesis. PBPs form stable covalent complexes with beta-lactam antibiotics, leading to PBP inactivation and ultimately cell death. To understand more clearly how PBPs recognize beta-lactam antibiotics, it is important to know their energies of interaction. Because beta-lactam antibiotics bind covalently to PBPs, these energies are difficult to measure through binding equilibria. However, the noncovalent interaction energies between beta-lactam antibiotics and a PBP can be determined through reversible denaturation of enzyme-antibiotic complexes. Escherichia coli PBP 5, a D-alanine carboxypeptidase, was reversibly denatured by temperature in an apparently two-state manner with a temperature of melting (T(m)) of 48.5 degrees C and a van't Hoff enthalpy of unfolding (H(VH)) of 193 kcal/mole. The binding of the beta-lactam antibiotics cefoxitin, cloxacillin, moxalactam, and imipenem all stabilized the enzyme significantly, with T(m) values as high as +4.6 degrees C (a noncovalent interaction energy of +2.7 kcal/mole). Interestingly, the noncovalent interaction energies of these ligands did not correlate with their second-order acylation rate constants (k(2)/K'). These rate constants indicate the potency of a covalent inhibitor, but they appear to have little to do with interactions within covalent complexes, which is the state of the enzyme often used for structure-based inhibitor design.
Related Compounds
Related Articles:
2012-10-01
[Antimicrob. Agents Chemother. 56(10) , 5157-63, (2012)]
2007-04-01
[J. Antimicrob. Chemother. 59(4) , 763-6, (2007)]
2002-02-01
[J. Antimicrob. Chemother. 49(2) , 315-20, (2002)]
Subclinical syphilitic hepatitis, which was markedly worsened by a Jarisch-Herxheimer reaction.
1999-06-01
[Am. J. Gastroenterol. 94(6) , 1694-6, (1999)]
Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
2001-07-10
[Biochemistry 40(27) , 7992-9, (2001)]